Chiesi Appoints David Khougazian Group

Chiesi Group announced a leadership change on September 15, 2026. Chiesi appointed former Flagship Pioneering executive David Khougazian as Group CEO, succeeding Interim Group CEO Jean-Marc Bellemin, to lead its next phase of innovation-driven growth.

What changed

David Khougazian was named Group Chief Executive Officer. Khougazian succeeds Interim Group CEO Jean-Marc Bellemin, who has led the Group since May 15, 2026 and continues in his permanent role as Group CFO.

Leader: David Khougazian
Role: Group Chief Executive Officer
Effective: October 15, 2026
Announcement date: September 15, 2026

Leadership background

Khougazian has an international career of more than 25 years across the global healthcare and life sciences sectors, the company said. He most recently served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he worked with leadership teams on long-term value creation, partnerships, financing, and organizational development.

The mandate

In the release, Khougazian said he looks forward to working alongside Chiesi colleagues around the world to further strengthen the Group’s innovation capabilities and advance its pipeline and partnerships. The company said it remains committed to its patient-centric strategy, advancing innovation across its therapeutic areas, and delivering sustainable growth.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Chiesi Group